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Abstract 
The searches of various literatures have shown the genus Isodon to be a source of different 
compounds with interesting biological activities. The genus has provided many efficacious herbal 
medicines that are used in various countries including China; therefore, it has become the centre of 
attention to phytochemistry and pharmacology researchers. There are many reports on chemical 
and biological aspects of Isodon species, especially in China and other parts of the world; 
however, reports on African Isodon species are scanty. Since the literature indicates the genus to 
be rich in diterpenoids with potential therapeutic activities as revealed herein, with African species 
waiting to be explored, it is the responsibility of the phytochemists and pharmacologists to fill this 
knowledge gap. Herein, ethnomedicinal uses of some of Isodon plants in various traditional 
medicine systems, phytochemistry of the genus from 2016 to date, synthesis of Isodon 
diterpenoids and derivatives are discussed.  
 




Natural products are chemical substances 
that are obtained from nature (animals, plants, 
micro-organisms and others). These 
compounds are known to possess distinctive 
biological properties, thus play vital role in 
the medicinal chemistry fields. Among many 
classes of natural compounds, terpenoids have 
emerged to be one of the main groups used as 
either drugs or drug intermediates. Literatures 
have indicated majority of terpenoids to be 
extracted from various plant sources, and very 
few have been isolated from other sources 
such as animals and microbes (Borowitzka 
1995, Martin et al. 2003, Zwenger and Basu 
2008). 
Isodon, a genus belonging to the family 
Labiatae (= Lamiaceae), is comprised of ~150 
species with most of them distributed in 
tropical and subtropical Asia. Although the 
genus is reported to be endemic to China, a 
few species have been observed in Africa, 
which include Isodon ramosissimus and 
Isodon schimperi (Harley et al. 2004). Many 
plants of this genus are known for their 
fragrant leaves and attractive flowers; thus, it 
is not surprising to find them used for 
decoration, in flavouring and in making 
fragrants (Venkateshappa and Sreenath 2013). 
The contribution of Isodon species 
(Xihuangcao in Chinese) in traditional 
medicine is unquestionable, especially in 
Chinese traditional medicine system. 
Generally, in Chinese traditional medicine 
systems, Isodon plants are used for treatment 
of acute hepatitis, trauma, dysentery, enteritis, 
bacterial infections, and inflammation. They 
are also known for their hepatoprotective 
effects, and treatment of sore throats, malaria, 
jaundice, pneumonia, gastrointestinal 
disorders and cholecystitis (Lianzhu et al. 
2011). In China, beverages and healthcare 




foods from Isodon plants are widely used for 
refreshments as well as treating various 
illnesses. Recently, Isodon products have 
gained acceptance by many people in China 
and other parts of the world (Lianzhu et al. 
2011). Owing to their effectiveness in 
treatments of various illnesses, the plants of 
this genus have been the centre of attention to 
researchers of various fields of science 
(Dilshad et al. 2008, Chen et al. 2009, Kang 
et al. 2010, Gu et al. 2010, Yu et al. 2014, 
Abbasi et al. 2019, Janbaz et al. 2014). While 
so much has been done in China and other 
countries concerning these species, scientific 
reports on these plants in Africa are scanty. It 
is the intention of this paper to provide an 
overview summary of applications of this 
genus in traditional medicine, phytochemistry 
and biological activities, and spearheading 




There are various literatures available on 
the uses of Isodon plants in traditional 
medicine, their phytochemistry, 
pharmacological activities, and various 
synthetic approaches designed for bioactive 
Isodon compounds (Dilshad et al. 2008, Chen 
et al. 2009, Kang et al. 2010, Gu et al. 2010, 
Akhtar et al. 2013, Ahmad et al. 2014, Shuaib 
and Khan 2015, Zhao et al. 2017, Abbasi et 
al. 2019, Janbaz et al. 2014). Although there 
are not many reviews on the subject, an 
excellent review by Liu et al. (2017) dealt 
extensively with chemical constituents, 
biological activities and synthesis of Isodon 
bioactive compounds from 2005 to 2016. 
Other reviews including those of Smith and 
Njardarson (2018), and Li et al. (2018), 
focused on synthetic strategies towards 
maoecrystal V (1) and spirolactone-type 
diterpenoids, respectively. Despite these 
excellent reviews, it is the intention of this 
paper to provide updated detailed information 
on the phytochemistry and biological 
activities of compounds from the genus 
Isodon from 2016 to 2019, and recent 
synthetic approaches of pharmacologically 
active Isodon diterpenoids and derivatives. 
For the stated objective to be achieved, 
collection, documentation and analysis of 
information concerning the uses of these 
plants in traditional medicine, 
phytochemistry, biological activities, and 
synthetic approaches of these compounds 
were done. Thus, literature searches were 
done by using search engines such as Science 
Direct, Springer Link, and Google Scholar, 
whereby combinations of key words like 
Isodon diterpenoids, Isodon medicinal uses, 
Isodon phytochemistry, Isodon diterpenoids 
synthetic approaches were used to obtain 
information needed. A total of over 1000 
publications were obtained on the subject; 
however, upon screening basing on their 
publication dates and relevance to the review 
topic, about 100 were selected. Before the 
literatures were deemed as unfit for the topic, 
they were thoroughly read and analysed. 
 
Results and Discussion 
Review on the use of Isodon plants in 
traditional medicine 
The contributions of plants in the battle 
against diseases in man, livestock and wildlife 
can be traced back since the existence of man. 
Thus, use of medicinal plants in various 
communities for disease control is as old as 
the human civilization itself. In Chinese 
traditional medicine system, fresh leaves of I. 
rugosus Wall. ex Benth. are renowned for 
relieving tooth pains, and the bark of the plant 
is used against dysentery and to alleviate 
body, abdominal and gastric pains (Akhtar et 
al. 2013, Ahmad et al. 2014, Shuaib and Khan 
2015). The plant is used against various skin, 
ear, nose, throat and intestine infections 
(Kang et al. 2010). One to two (1-2) drops of 
the fresh leaves extract of the plant are used 
against ear pains, also rubbing the extract on 
the affected area is known to relieve pains. 
The plant is also used against microbial 
infections, blood pressure, dysentery, 
hypoglycemic, pyrexia, and rheumatism 
(Khan and Khatoon 2007, Adnan et al. 2012, 
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Shuaib et al. 2014). Furthermore, the plant is 
used as anti-septic and bronchodilator agent 
(Xu et al. 2010, Liu et al. 2012). For curing 
reproductive disorders in cattle, the boiled 
decoction of the plant is used (Dilshad et al. 
2008). Pharmacological activities evaluations 
on the plant extract showed anti-emetic, anti-
spasmodic, anti-pyretic (Janbaz et al. 2014) 
and anti-fungal (Rauf et al. 2012) potentials. 
Moreover, the plant extracts have been shown 
to exhibit anti-bacterial, anti-oxidant and 
lipoxygenase inhibitor activities (Gu et al. 
2010). The analgesic potential evaluation of 
the chloroform fraction showed 53% 
analgesia in acetic acid induced writhing, and 
in formalin test the extract inhibited pain by 
61% and 45% at phase-I and –II, respectively 
(Kong et al. 2014). Moreover, Siddiquah et al. 
(2018) investigated zinc oxide nanoparticles 
made from I. rugosus. It was reported that the 
particles showed superior anti-cancer and 
anti-microbial activities as compared to the 
extract alone. This led to the conclusion that 
biogenic zinc oxide natural products have 
extraordinary potential against cancer and 
microbes (Siddiquah et al. 2018). Essential 
oils extracted from I. rugosus demonstrated 
strong anti-nociceptive activity, by acting on 
the central pathway of nociception. Moreover, 
the oils showed free radicals scavenging 
activity with IC50 values of 338 and 118 
μg/mL for 1,1-diphenyl-2-picryl-hydrazyl 
(DPPH) and 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid (ABTS) 
free radicals, respectively. Cholinesterases 
inhibitory activities of these essential oils 
were reported to give IC50 values of 93.56 and 
284.19 μg/mL by AChE and BChE, 
respectively (Sadiq et al. 2018). Last, but not 
the least, the production of anti-oxidant and 
anti-aging compounds (cosmetic potential) of 
I. rugosus (Wall. ex Benth.) Codd was 
evaluated using in vitro callus induction from 
stem and leaf explants under various plant 
growth regulators. The stem derived explants, 
the plant growth regulator thidiazuron alone 
or in combination with naphthalene acetic 
acid induced highest callogenesis. Thus, the 
anti-oxidant activities of these samples under 
optimum hormonal combinations were 
reported to be 3.0 mg/L TDZ + 1.0 mg/L 
NAA. Their constituents were found to be 
plectranthoic acid (2) at 373.92 µg/g dry 
weight (dw), oleanolic acid (3) at 287.58 µg/g 
dw, betulinic acid (4) at 90.51 µg/g dw, 
caffeic acid (5) at 91.71 µg/g dw, and 
rosmarinic acid (6) at 1732.61 µg/g dw. It 
was further reported that compound 6 was the 
main contributor in the observed anti-oxidant 
and anti-aging activities (Abbasi et al. 2019). 
 
I. flavidus (Hand.-Mazz.) H. Hara, a 
perennial herb from Yunnan and Guizhou 
province (China) has been used as an anti-
fungal agent (Li et al. 2016a). I. coetsa is used 




in traditional Chinese medicine system 
against inflammation, tumours and bacterial 
infections (Neelamkavil and Thoppil 2014). I. 
kameba and I. pervifolius are locally used in 
China against tumours; this correlated well 
with the scientific findings, where the plants 
extracts were found to exhibit anti-tumour, 
cytotoxic and anti-bacterial activities (Zhou et 
al. 2014). 
In Chinese traditional medicine system, 
the leaves of I. rubescens (Hemsl.) H. Hara or 
“donglingcao” in Chinese have been used for 
the healing of respiratory and gastrointestinal 
bacterial infections, inflammation, and 
cancer. Due to its wide use in Chinese 
ethnomedicine systems, the plant extract was 
developed into a drug formulation for 
treatments of sore throats and inflammation 
(Chen et al. 2009, Tan et al. 2011). Scientific 
studies revealed that the anti-cancer activities 
of the plant extract proceed through inhibiting 
NF-κB signalling. The isolation of oridonin 
(7), a compound renowned for anti-cancer 
activity confirmed the ethnomedical uses of 
the plant (Sun et al. 2006). 
From the above discussion, it is evident 
that plants of the genus Isodon from Africa do 
not feature in the literature so far surveyed. 
Now, considering the facts that the genus is a 
valuable resource for pharmacological 
research, and scientific reports on these plants 
in Africa are scanty, then, it is important for 
phytochemists and pharmacologists to focus 
on these plants, so as to reveal the structures 
of their compounds and their respective 
pharmacological significance.  
 
Review on phytochemistry of the genus 
Isodon from 2016-2019 and synthesis 
The isolation of compound 1 and 
derivatives (Zhou et al. 2007, Kang et al. 
2010, Xu et al. 2017), eriocalyxin B (8) 
(Kong et al. 2014), adenanthin (9) (Liu et al. 
2012), and pharicins A (10) (Xu et al. 2010) 
and B (11) (Gu et al. 2010), coupled with 
medicinal applications of the plants of genus 
Isodon, have fuelled extensive phytochemical 
as well as pharmacological studies towards 
these plants.  
The investigations on Isodon 
diterpenoids began as early as 1910 when 
bitter principle from “enmei-so” was isolated 
by Yagi and named it plectranthin (Yagi 
1910). However, the structure of plectranthin 
(also called enmein) was not yet established 
until 1966 when for the first time X-ray 
crystallography showed the structure to be 




An excellent review of the 
phytochemistry of this genus from 2005 to 
2016 was provided by Liu et al. (2017), 
however, vast diversity of Isodon diterpenoids 
have been discovered since 2016 to date. 
Therefore, about 120 new compounds with 
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different oxygenation and their respective 
biological activities are described herein. 
Aerial parts of I. eriocalyx yielded 
maoeriocalysins A–D (7–16), however, to 
date, there are no reports on the 
pharmacological properties of the compounds 
(Yang et al. 2019). From the same plant, Li et 
al. (2018) investigated anti-inflammatory 
activities of the plant extract and its bioactive 
constituent eriocalyxin B (17). Both plant 
extract and compound 17 enhanced the 
cytotoxic and apoptotic effects of gemcitabine 
in pancreatic cancer cells by regulating 
PDK1/AKT1/caspase and JNK signaling (Li 





acetylangustifolin (18) and 11-O-
acetylangustifolin (19), and a glycosidic 
iridoid, 6-O-veratroylbarlerin (20), and 7,20-
epoxy-ent-kaurane diterpenoids, 
isojiangrubesins A-G (21–27) were isolated 
from aerial parts of I. rubescens (Hemsl.) H. 
Hara. Compounds 18 and 19 exhibited 
cytotoxic activities against human lung cancer 
cell lines A549 and leukemia cell lines K562 
(Luo et al. 2018). However, there are no 
reports on the biological activities potential 
for compound 20 (Belaabed et al. 2018). 
Compounds 21–27 were evaluated for their 
inhibitory effects on LPS-activated NO 
production in RAW264.7 cells. Therefore, 
compounds 22 and 25, exhibited potent 
activities with IC50 values of 1.2 and 1.3 
µg/mL, respectively. Better still, the 
compounds showed lower toxicity upon in 
vitro testing against five human tumour cell 
lines (HL-60, SMMC-7721, A-549, MCF-7, 




Matsumoto and group (2017) reported 
terpenes I (28) and II (29) from aerial parts of 
I. japonica. The compounds exhibited anti-
mutagenic activities (Matsumoto et al. 2017). 





Aerial parts of I. pharicus yielded compounds 
30–41, and twenty one 7α,20-epoxy-ent-
kaurane diterpenoids, pharicins C−W 
(42−62). Compounds 37 and 38 exhibited 
significant inhibitory effects against HL-60, 
SMMC-7721, A-549, MCF-7, and SW-480 
human tumour cell lines, at IC50 values 
ranging from 0.37 to 6.03 μM (Hu et al. 
2018a). Compounds 52 and 57 showed 
inhibitory activities at IC50 values ranging 
from 1.01 to 9.62 μM against HL-60, SMMC-
7721, A-549, MCF-7, and SW-480 tumour 
cell lines, the rest exhibited moderate 




Talienosides A (63) and B (64) were 
isolated from underground parts of I. 
taliensis. Compound 63 inhibited α-
glycosidase and β-hematin formation with 64 
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demonstrating weaker inhibitory activity 
(Xiang et al. 2018). Hu et al. 2019 isolated 
adenanthin (65) from aerial parts of I. 
adenantha, the compound showed increase in 
intracellular reactive oxygen species in 
leukemic and hepatocellular carcinoma cells. 
Furthermore, the compound inhibited 
adipogenesis of 3T3-L1 and mouse 
embryonic fibroblasts‟, therefore, reducing 
significantly weight and adipose tissue mass 
in mice (Hu et al. 2019). 
 
 
Aerial parts of I. serra yielded four ent-
abietanoids, namely, serrin K (66), 
xerophilusin XVII (67), and enanderianins Q 
and R (68 and 69), and nine 7,20-epoxy-ent-
kaurane diterpenoids, namely, 15-
acetylmegathyrin B (70), serrin E (71), 14b-
hydroxyrabdocoestin A (72), serrin F (73), 
serrin G (74), 11-epi-rabdocoestin A (75), 
serrin H (76), serrin I (77), and 15-
acetylenanderianin N (78). Compound 66 
inhibited NO production in LPS-stimulated 
RAW264.7 cells (IC50 = 1.8 µM), with weak 
cytotoxicity on five human tumour cell lines 
(HL-60, SMMC-7721, A-549, MCF-7, 
SW480) (Wan et al. 2017). Compounds 73, 
74, 76 and 77 strongly inhibited NO 
production in LPS-stimulated RAW264.7 
cells, however, with exception of 73 that 
exhibited cytotoxicity against HL-60, 
SMMC-7721, A-549, MCF-7, SW480, the 
rest showed no cytotoxicity (Wan et al. 2016). 
 
Isoscoparins R (79) and S (80), and 
diterpenoids 81−94, and scopariusols L–T 
(95–103) were isolated from aerial parts of I. 
scoparius. Compound 80 showed weak 
activity as autophagic inhibitor (Li et al. 
2019). Compounds 81, 82 84 and 95 
exhibited cytotoxic activity against five 
human tumor cell lines (HL-60, SMMC-7721, 
A-549, MCF-7, and SW-480). The four 
compounds inhibited NO production in LPS-
stimulated RAW264.7 cells, at IC50 = 1.0, 3.1, 
1.8 and 0.6 μM, respectively (Jiang et al. 
2017, Jiang et al. 2018). 







Amethinol (104) was isolated from I. 
amethystoides, the compound showed 78% 
inhibition of luciferase activity at 10 µg/ml 
(Zhao et al. 2018).  The structural 
modification of compound 1 gave jesridonin 
(105), which effectively prevented the growth 
of paclitaxel-resistant human oesophageal 
carcinoma cells EC109 with low toxicity. 
Also the compound significantly inhibited the 
proliferation, induced apoptosis and arrested 
the cell cycle at the G2/M phase on EC109 
cells. The mechanism for the expressed 
activity included up-regulating the expression 
of p53, modulator of apoptosis (PUMA), 
cleaved-caspase-9 and caspase -3. 
Furthermore, the compound down-regulated 
the expressions of procaspase-3, -9 and Bcl-2 
in the EC109 in concentration-dependent 
manners (Wang et al. 2017). 
I. ternifolius (aerial parts) yielded 
ternifoliusins A-I (106–114), with compounds 
106–109 possessing a rare 6, 7, 8, 15- diseco-
7,20-olide-6,8-cyclo-ent-kaurane skeleton. 
Lower cytotoxicity activity against the HL-
60, SMMC-7721, A-549, MCF-7, and SW-
480 human tumour cell lines was observed for 
all the compounds (Gou et al. 2019). 





Isoforretin A (115) and four ent-abietane 
diterpenoids named as isoforrethins A–D (116 
- 119) were isolated from aerial parts of I. 
forestii var. forestii. Compound 115 exhibited 
anti-tumour effects by triggering ROS 
mediated anti-tumor effects and inhibiting 
thioredoxin-1 (Sun et al. 2017). Significant 
inhibitory activities against SMMC-7721, A-
549, MCF-7, and SW-480 was shown by 
compound 119 (Chen et al. 2019). 
 
Fladin A (120), consisting of an 
unprecedented cyclic ether group between C-
4 and C-9, and lophanic acid (121) were 
isolated from aerial parts of I. flavidus. 
Compound 121 exhibited MIC value of 7.8 
µg/mL, against athlete‟s foot fungus 
Trichophyton rubrum (Li et al. 2016a). 
Four phyllostachysins I - L (122–125) and 
phyllostachysins M–P (126–129) were 
isolated from aerial parts of I. phyllostachys. 
Compounds 124 and 125 showed significant 
cytotoxic activities, and strongly inhibited the 
production of NO in LPS-stimulated 
RAW264.7 cells (Yang et al. 2016). 
Compounds 126–129 exhibited lower 
cytotoxic activities with IC50 > 10 µM (Yang 
et al. 2017). 
 






A 7,20-epoxy kaurane diterpenoid, 15-
acetyldemethylkamebacetal A (130) was 
extracted from aerial parts of I. inflexus. The 
compound showed NF-κB inhibitory 
activities with IC50 = 20.15 μM (Xu et al. 
2016). An abietane glycoside, rugosodon 
(131), and compound 6 were isolated from the 
roots and aerial parts of I. rugosus Wall Ex 
Benth, respectively. Compound 131 exhibited 
significant α-glucosidase inhibitory activity 
with IC50 value of 0.453 mg/mL (Ullah et al. 
2019). Compound 6 showed activity against 
pea aphid, Acyrthosiphon pisum, with LC90 
value of 5.4 ppm (Khan et al. 2019). 
 
In summary, diterpenoids from the genus 
Isodon have shown impressive anti-
inflammatory, anti-fungal, insecticidal and 
other pharmacological effects with minimum 
cytotoxicity. However, the above discussion 
reveals that plants of the genus Isodon from 
Africa have so far not been scientifically 
investigated. Therefore, this serves to draw 
the attention of phytochemists and 
pharmacologists to work together to reveal 
the structures of the compounds and the 
detailed mechanisms of their biological 
activities for the benefits of drug discovery 
processes. It is interesting to note that, in 
some literatures discussed above, 
reinvestigations of the same species yielded 
different compounds (Zhang et al. 2017, Yang 
et al. 2019, Li et al. 2018, Luo et al. 2018, 
Belaabed et al. 2018, Hu et al. 2018a, Hu et 
al. 2018b). In chemotaxonomic point of view, 
it should be noted that changes in ecological 
environment can bring changes in secondary 
metabolites produced by the plant. Therefore, 
it is expected that African Isodon species 
would yield different compounds with 
different oxygenation. This is an open area of 
research to unveil the structures and 
pharmacological potentials of components 
from Isodon species occurring in Africa. 
Furthermore, owing to the interesting 
pharmacological, molecular structures 
expressed by these compounds, and 
sustainable use of the resources, synthesis of 
these compounds becomes vital.  
An in-depth review on synthetic methods 
of compound 1 and spirolactone-type 
diterpenoids have been provided by Smith 
and Njardarson (2018), and Li et al. (2018), 
respectively. However, in this review, a 
summary of the synthesis of the compounds 
that were not reviewed in the mentioned 
papers is given. For complete synthetic 
schemes of the summarized syntheses, the 
original articles must be consulted. Su et al. 
(2018) utilized highly diastereo- and 
regioselective intermolecular Diels–Alder 
cycloaddition reactions in synthesizing the 
anti-tumour natural product maoecrystal P 
(132). The reactions involved a diene present 
in a substituted bicyclo[4.1.0] system in 
assembling most of the carbon centres. The 
construction of the D-ring was achieved by 
reduction of 133 under DIBAL-H, followed 
by oxidation, to yield 134. Transformation of 
compound 134 to 135 that consisted of a 
sterically hindered quartenary carbon and a 
strained ring system completed the ent-
kauranoid skeleton system. Isomerization of 
136a under 2,2-dimethoxypropane in the 
presence of catalytic tosylic acid afforded 
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137. Intramolecular conjugate addition and 
oxidation of C7 alcohol ultimately yielded 
132 as summarized in Scheme 1. 
Scheme 1: Summarized synthesis of compound 132. 
 
Convenient methods for synthesizing 
both trichorabdal A (138) and maoecrystal Z 
(139) was reported by Lv et al. (2018). The 
group generated a common intermediate 
between the two structures, which is 
bicyclo[3.2.1]octane by a series of 
retroaldol/aldol reaction. Not only that, but 
also, they utilized cross-ring radical 
cyclization to construct all quaternary carbon 
centres in the Isodon diterpenoids, and Ueno–
Stork cyclization on to 1,6-enone system, to 
yield the target molecules. Towards 
synthesizing a common intermediate, the 
group proceeded with oxidative 
dearomatization to yield 140, and then 
converted to Ueno-Stork cyclization substrate 
141. 1,4-addition to break 1,6-enone system, 
followed by radical cyclization, and a series 
of reduction followed by double Swern 
oxidation and treatment with Seyfertg-Gilbert 
reagent to alkyne 142. Acid hydrolysis 
afforded enone system, followed by 
construction of the bicycle[3.2.1]octane ring 
system using radical cyclization to 143. In 
several steps, a common intermediate, 144 
was obtained. With the availability of 144, 
syntheses of compounds 138 and 139 were 
completed as described in Scheme 2. 




Scheme 2: Summarized synthesis of compounds 138 and 139. 
 
Zhao et al. (2017) synthesized 1α,6α-
diacetoxy-ent-kaura-9(11),16-dien-12,15-
dione (145) and lungshengenin D (146) by 
installing the [3.2.1] bicyclic motif at earlier 
stages. The group utilized Hoppe‟s homoaldol 
reaction of an aldehyde and cyclohexenyl 
carbamate, followed by intramolecular 
Mukaiyama-Michael reaction to obtain the 
tetracyclic core structure of ent-kaurane 
diterpenoids. The synthesis of the two 
compounds was achieved through synthesis 
of the common intermediate 147. Compound 
147 was subjected into various reactions 
through several steps to obtain 146. Selective 
reduction of C-12 carbonyl group of 147, 
after a series of reactions, enone 148 was 
obtained. Lastly, selective epoxidation of 148, 
followed by reduction to alcohol 149, 
hydroxyl directed reduction to control 
stereochemistry at C1, followed by 
regioselective acetylation yielded 146 
(Scheme 3).   
 
 
Bioactive enmein-type NO-releasing 
diterpenoids derivatives were synthesized 
according to Scheme 4, and their biological 
potentials were reported by Li et al. (2016b). 
Of all the derivatives prepared, it was 
indicated that compounds 153 and 155 were 
the most anti-bacterial with MIC values of 2 
and 4 µg/mL, respectively against S. aureus 
and B. subtilis. The observed activity might 
be due to the influence of the total length of 
the compound (Li et al. 2016b).  All 
compounds showed higher effectiveness 
against K562 leukemia cell line, MGC-803 
gastric cancer cell line, CaEs-17 oesophageal 
cancer cell line, and Bel-7402 hepatoma cell 
line than compound 7. Derivative 157 showed 
stronger activity with IC50 of 0.72 µM than 
that of taxol (1.89 µM), and generally it was 
reported that derivatives 154, 157, and 160 
demonstrated superior activities than the rest; 
this might be due to the presence of aromatic 
rings that might be influencing the binding 
properties of the molecules (Li et al. 2016b). 




Scheme 3: Summarized synthesis of compounds 145 and 146. 
 
 
Scheme 4: Total synthesis of enmein-type NO-releasing diterpenoids. 
 
Discussion 
The literatures summarized in this paper 
have shown the diterpenoids richness of the 
genus Isodon and their respective 
pharmacological properties. It is also shown 
that plants of genus Isodon have great 
potential in health care and disease control. 
Nevertheless, the applications of these plants 
for health and disease control in African 




countries require further scientific 
investigation/analysis. 
So far, Isodon ramosissimus (Hook. f.) 
candd. (Figure 1) is the only species that has 
been identified in Tanzania. Its specific 
locations are in Kungwe Mountain, Kahoko, 
Ukaguru Mountains, Mandege-Vingwete, 
Lulanda Escarpment, and Fufu stream. In 
Africa, the plant is distributed in Sierra 
Leone, Nigeria, Cameroon, Equatorial 
Guinea, Congo-Kinshasa, Rwanda, Burundi, 
Sudan (Imatong Mountains), Ethiopia, 
Angola, Zambia, Malawi, Zimbabwe, Kenya 
and Uganda. The habitats in which the plant 
is mostly found include forest undergrowth 
and margins, upland grassland, descending to 
lower altitudes along rivers at about 750 – 
2100 M (Paton et al. 2009). 
 
  
Figure 1: Herbarium specimens of Isodon ramosissimus (Hook. f.) candd (Pictures from the 
Herbarium, Botany Department, University of Dar es Salaam). 
 
Another Isodon species identified in 
Africa is Isodon schimperi (shrub, subshrub, 
and perennial herb), which is distributed in 
Central Africa, Ethiopia, Rwanda and 
Burundi. Generally, the plant grows in 
medium altitude, and montane forest, usually 
along margin, and montane grasslands (Yu et 
al. 2014).  Since scientific reports on these 
plants are scanty, phytochemists are 
enlightened on this area of research. It is 
known that the same species of plants in 
different geographical and ecological 
conditions possess different secondary 
metabolites, biological potentials and 
sometimes different mechanisms of action, 
then, structures, potentials against tropical 
diseases and mechanisms of activities are 
waiting to be revealed. As indicated above, 
Isodon species have shown reputed biological 
potential, and in China, Isodon based products 
have been formulated for disease control. 
Since large proportions of the population 
worldwide use herbal medicines/formulations 
as medicines or supplements, phytochemists 
and pharmacologists are enlightened to this 
open area of research towards developing 
products for various uses including health, 
beauty and others. For example, although it 
needs further investigations, products of 
compound 65 that has been proven to reduce 
significantly weight and adipose tissue mass 
in mice, could be developed to reduce health 
effects related to obesity.  The products might 
be in the form of concoctions, teas, powder, 
tablets and others. To reduce the problem of 
bioavailability and enhance bioactivity of the 
products, the introduction of pharmaceutical 
additives proven to enhance bioavailability of 
natural products is highly recommended. 
These include quercetin, genistein, naringin, 
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efficacious herbal drugs, and different lead 
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compounds with varieties of biological 
activities. There are many reports on chemical 
and biological aspects of Isodon species, but 
African species have not been scientifically 
investigated. The literature indicates the 
genus to be rich in diterpenoids with potential 
therapeutic activities, waiting to be explored. 
It is incumbent on scientific researchers to fill 
the gap created by the absence of knowledge 
concerning African Isodon species. This is 
because geographical as well as seasonal 
variations contribute largely to chemical 
compositions differences, thus, a need for 
authentication of chemical constituents, 
pharmacological potentials and synthetic 
methods of the compounds. For these to be 
fulfilled, the extensions of interdisciplinary 
researches leading to revealing structures, 
biological potentials as well as convenient 
synthetic methods are recommended. It is my 
hope that this review provides useful 
information to researchers in various fields, 
especially those dealing with drug discovery. 
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